Naroa Usandizaga-Goikoetxea

Bizkaia Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma.

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma.

Journal: Molecular oncology

Published: December 01, 2025

Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.

Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.

Journal: Science advances

Published: October 22, 2025

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.

Journal: Molecular metabolism

Published: October 19, 2025

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.

Journal: Clinical nutrition (Edinburgh, Scotland)

Published: October 16, 2025

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.

Journal: British journal of cancer

Published: June 26, 2025

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.

Journal: Hepatology (Baltimore, Md.)

Published: April 03, 2025

The disease-linked R336C mutation in cystathionine β-synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity.

The disease-linked R336C mutation in cystathionine β-synthase disrupts communication with the PLP cofactor, yet maintains the enzyme's overall structural integrity.

Journal: The FEBS journal

Published: December 02, 2024

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential.

Journal: Gut

Published: July 09, 2024

Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity.

Novel Emerging Mechanisms in Acetaminophen (APAP) Hepatotoxicity.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 29, 2024

NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity.

NEDDylation Regulates CD8+ T-cell Metabolism and Antitumor Immunity.

Journal: Cancer immunology research

Published: March 25, 2024

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.

Journal: Hepatology (Baltimore, Md.)

Published: March 23, 2024

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.

The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.

Journal: Metabolism: clinical and experimental

Published: February 22, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026